Physical Exercise on Simple Inflammatory Markers, Systemic Immune Inflammation Index, and Systemic Immune Response Index

The Effects of Physical Exercise on Simple Inflammatory Markers, Systemic Immune Inflammation Index, and Systemic Immune Response Index in Patients With Schizophrenia

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06574893

Enrollment

Registered

2024-08-28

Start date

2024-05-04

Completion date

2025-03-12

Last updated

2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical Exercise, Schizophrenia

Brief summary

Mental health is defined as a state of well-being in which a person can realize their talents, cope with the normal stresses of life, and support society by working efficiently and productively. In other words, mental health is a dynamic internal balance that enables individuals to use their diversity of skills in harmony with the universal values of society.

Detailed description

The aim of this study was to investigate the effect of physical exercise on simple inflammation markers, systemic immune inflammation index and systemic inflammation response index in patients with schizophrenia. No other study examining the effect of exercise on these parameters was found in the literature. Therefore, considering the importance of our study, our findings may contribute to the literature and improvement for mental health systems, especially for people with psychotic disorders such as schizophrenia.

Interventions

OTHERphysical exercise

physical exercise

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to 55 Years

Healthy volunteers

Yes

Inclusion criteria

* Individuals diagnosed with schizophrenia by a physician according to DSM-V criteria * Individuals with schizophrenia who are 18 -55 years

Exclusion criteria

* Those who do not consent to participate in the study Patients with a diagnosis other than schizophrenia Pregnancy Patients with chronic metabolic diseases such as diabetes, heart problems and cancer

Design outcomes

Primary

Measure	Time frame	Description
sociodemographic characteristics.	12 weeks	It will be asked to fill out a structured questionnaire covering their sociodemographic characteristics.
simple inflammatory markers	12 weeks	Index Calculation Based on Complete Blood Count

Secondary

Measure	Time frame	Description
Positive and Negative Syndrome Scale	12 weeks	Positive and Negative Syndrome Scale will be used for detecting positive and negative syndromes

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026